Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Insights from outside BJOG

Insights from outside BJOG DOI: 10.1111/1471-0528.14266 www.bjog.org Research snippets use of atosiban. None of the deaths were medicine showing any positive value of Threatened preterm birth attributable to the drugs’ use according to tocolysis, immediate or long-term (van When women present with threatened a panel of experts. There seems little to Vliet et al. BJOG 2016;123:1107–14). Surely preterm labour, perinatologists have a choose between the two drugs in terms of this is not a satisfactory situation? wide range of options. If the belief is that tocolytic efficiency as measured by neona- labour is ongoing and the gestational age tal results. But, as Walker and Thornton is <34 weeks then delaying birth for 24– Preterm birth and progesterone point out (Lancet 2016;387:2068–70), there 48 hours will allow for the administration Preterm birth remains the greatest obstet- are no controlled trials demonstrating the of maternal corticosteroids and for trans- ric challenge in terms of neonatal morbid- advantages of drug interventions in the port of the mother to a place where opti- ity and mortality. Over a million children a inhibition of threatened preterm labour. mal neonatal facilities are available. year die as a consequence of preterm deliv- Obstetricians continue to act on their clini- Options http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BJOG : An International Journal of Obstetrics & Gynaecology Wiley

Insights from outside BJOG

Download PDF
5 pages

Loading next page...
 
/lp/wiley/insights-from-outside-bjog-mqiPOLj0go

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2016 Royal College of Obstetricians and Gynaecologists
ISSN
1470-0328
eISSN
1471-0528
DOI
10.1111/1471-0528.14266
Publisher site
See Article on Publisher Site

Abstract

DOI: 10.1111/1471-0528.14266 www.bjog.org Research snippets use of atosiban. None of the deaths were medicine showing any positive value of Threatened preterm birth attributable to the drugs’ use according to tocolysis, immediate or long-term (van When women present with threatened a panel of experts. There seems little to Vliet et al. BJOG 2016;123:1107–14). Surely preterm labour, perinatologists have a choose between the two drugs in terms of this is not a satisfactory situation? wide range of options. If the belief is that tocolytic efficiency as measured by neona- labour is ongoing and the gestational age tal results. But, as Walker and Thornton is <34 weeks then delaying birth for 24– Preterm birth and progesterone point out (Lancet 2016;387:2068–70), there 48 hours will allow for the administration Preterm birth remains the greatest obstet- are no controlled trials demonstrating the of maternal corticosteroids and for trans- ric challenge in terms of neonatal morbid- advantages of drug interventions in the port of the mother to a place where opti- ity and mortality. Over a million children a inhibition of threatened preterm labour. mal neonatal facilities are available. year die as a consequence of preterm deliv- Obstetricians continue to act on their clini- Options

Journal

BJOG : An International Journal of Obstetrics & Gynaecology – Wiley

Published: Sep 1, 2016

There are no references for this article.